1. Home
  2. GERN vs SEB Comparison

GERN vs SEB Comparison

Compare GERN & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • SEB
  • Stock Information
  • Founded
  • GERN 1990
  • SEB 1918
  • Country
  • GERN United States
  • SEB United States
  • Employees
  • GERN N/A
  • SEB N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • SEB Farming/Seeds/Milling
  • Sector
  • GERN Health Care
  • SEB Industrials
  • Exchange
  • GERN Nasdaq
  • SEB Nasdaq
  • Market Cap
  • GERN 2.5B
  • SEB 2.4B
  • IPO Year
  • GERN 1996
  • SEB N/A
  • Fundamental
  • Price
  • GERN $3.34
  • SEB $2,484.47
  • Analyst Decision
  • GERN Strong Buy
  • SEB
  • Analyst Count
  • GERN 10
  • SEB 0
  • Target Price
  • GERN $7.05
  • SEB N/A
  • AVG Volume (30 Days)
  • GERN 8.0M
  • SEB 2.7K
  • Earning Date
  • GERN 11-07-2024
  • SEB 02-11-2025
  • Dividend Yield
  • GERN N/A
  • SEB 0.36%
  • EPS Growth
  • GERN N/A
  • SEB N/A
  • EPS
  • GERN N/A
  • SEB N/A
  • Revenue
  • GERN $29,480,000.00
  • SEB $8,900,000,000.00
  • Revenue This Year
  • GERN $32,021.10
  • SEB N/A
  • Revenue Next Year
  • GERN $298.14
  • SEB N/A
  • P/E Ratio
  • GERN N/A
  • SEB N/A
  • Revenue Growth
  • GERN 9199.68
  • SEB N/A
  • 52 Week Low
  • GERN $1.64
  • SEB $2,413.00
  • 52 Week High
  • GERN $5.34
  • SEB $3,796.00
  • Technical
  • Relative Strength Index (RSI)
  • GERN 25.88
  • SEB 35.64
  • Support Level
  • GERN $3.75
  • SEB $2,425.00
  • Resistance Level
  • GERN $4.00
  • SEB $2,507.66
  • Average True Range (ATR)
  • GERN 0.17
  • SEB 69.63
  • MACD
  • GERN -0.06
  • SEB -2.49
  • Stochastic Oscillator
  • GERN 7.41
  • SEB 28.07

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About SEB Seaboard Corporation

Seaboard Corp is a diversified group of companies that operate in agricultural and ocean transport businesses. The company is engaged in hog production and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group operates six business segments: pork, commodity trading and milling, marine, sugar and alcohol, power, turkey and others. It operates in 45 countries, with a concentration in the U.S. and countries in Central and South America and Africa.

Share on Social Networks: